Shanghai ChemPartner Co., Ltd. and Agios Pharmaceuticals Expand Cancer Drug Collaboration
7/10/2009 11:22:57 AM
ChinaBio Today -- Shanghai ChemPartner has expanded its drug discovery research collaboration with Agios, a Cambridge, Massachusetts biopharma seeking to develop novel drugs that target the metabolism of cancer. Agios is striving to develop drugs that inhibit the growth of tumors by starving them. The company is based on its founders’ discovery that a change in metabolism drives tumor growth, rather than the metabolism change occurring as a consequence of the cancer.